Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shyam Sundar

Showing results (611-620 of 905) with videos related to

Pageof 91
Sort By:
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|July 4, 2006
Mechanisms of experimental resistance of Leishmania to miltefosine: Implications for clinical useF Javier Pérez-Victoria, María P Sánchez-Cañete, Karin Seifert, et al.
Journal of Clinical Microbiology|June 23, 2021
Utility of Blood as the Clinical Specimen for the Molecular Diagnosis of Post-Kala-Azar Dermal LeishmaniasisKeerti Kaumudee Dixit, V Ramesh, Shreya Upadhyay, et al.
Plos One|September 4, 2014
Exposure to Phlebotomus argentipes (Diptera, Psychodidae, Phlebotominae) sand flies in rural areas of Bihar, India: the role of housing conditionsParitosh Malaviya, Epco Hasker, Albert Picado, et al.
International Journal of Epidemiology|September 5, 2014
Health & Demographic Surveillance System profile: the Muzaffarpur-TMRC Health and Demographic Surveillance SystemParitosh Malaviya, Albert Picado, Epco Hasker, et al.
Plos Neglected Tropical Diseases|October 3, 2014
Leishmania specific CD4 T cells release IFNγ that limits parasite replication in patients with visceral leishmaniasisRajiv Kumar, Neetu Singh, Shalini Gautam, et al.
Biomaterials Science|August 26, 2022
Hijacking the intrinsic vitamin B<sub>12</sub> pathway for the oral delivery of nanoparticles, resulting in enhanced <i>in vivo</i> anti-leishmanial activityAakriti Singh, Ganesh Yadagiri, Aaqib Javaid, et al.
Plos One|February 6, 2014
Risk factors for visceral leishmaniasis and asymptomatic Leishmania donovani infection in India and NepalAlbert Picado, Bart Ostyn, Shri Prakash Singh, et al.
Journal of Medical Entomology|May 20, 2017
Establishing, Expanding, and Certifying a Closed Colony of Phlebotomus argentipes (Diptera: Psychodidae) for Xenodiagnostic Studies at the Kala Azar Medical Research Center, Muzaffarpur, Bihar, IndiaPuja Tiwary, Shakti Kumar Singh, Anurag Kumar Kushwaha, et al.
Plos Neglected Tropical Diseases|January 23, 2009
Visceral leishmaniasis elimination programme in India, Bangladesh, and Nepal: reshaping the case finding/case management strategyDinesh Mondal, Shri Prakash Singh, Narendra Kumar, et al.
The American Journal of Tropical Medicine and Hygiene|August 19, 2017
The Phenotype of Circulating Neutrophils during Visceral LeishmaniasisSmriti Sharma, Shweta Srivastva, Richard E Davis, et al.
Pageof 91

Showing results (611-620 of 905) with videos related to

Sort By:
Pageof 91
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|July 4, 2006
Mechanisms of experimental resistance of Leishmania to miltefosine: Implications for clinical useF Javier Pérez-Victoria, María P Sánchez-Cañete, Karin Seifert, et al.
Journal of Clinical Microbiology|June 23, 2021
Utility of Blood as the Clinical Specimen for the Molecular Diagnosis of Post-Kala-Azar Dermal LeishmaniasisKeerti Kaumudee Dixit, V Ramesh, Shreya Upadhyay, et al.
Plos One|September 4, 2014
Exposure to Phlebotomus argentipes (Diptera, Psychodidae, Phlebotominae) sand flies in rural areas of Bihar, India: the role of housing conditionsParitosh Malaviya, Epco Hasker, Albert Picado, et al.
International Journal of Epidemiology|September 5, 2014
Health & Demographic Surveillance System profile: the Muzaffarpur-TMRC Health and Demographic Surveillance SystemParitosh Malaviya, Albert Picado, Epco Hasker, et al.
Plos Neglected Tropical Diseases|October 3, 2014
Leishmania specific CD4 T cells release IFNγ that limits parasite replication in patients with visceral leishmaniasisRajiv Kumar, Neetu Singh, Shalini Gautam, et al.
Biomaterials Science|August 26, 2022
Hijacking the intrinsic vitamin B<sub>12</sub> pathway for the oral delivery of nanoparticles, resulting in enhanced <i>in vivo</i> anti-leishmanial activityAakriti Singh, Ganesh Yadagiri, Aaqib Javaid, et al.
Plos One|February 6, 2014
Risk factors for visceral leishmaniasis and asymptomatic Leishmania donovani infection in India and NepalAlbert Picado, Bart Ostyn, Shri Prakash Singh, et al.
Journal of Medical Entomology|May 20, 2017
Establishing, Expanding, and Certifying a Closed Colony of Phlebotomus argentipes (Diptera: Psychodidae) for Xenodiagnostic Studies at the Kala Azar Medical Research Center, Muzaffarpur, Bihar, IndiaPuja Tiwary, Shakti Kumar Singh, Anurag Kumar Kushwaha, et al.
Plos Neglected Tropical Diseases|January 23, 2009
Visceral leishmaniasis elimination programme in India, Bangladesh, and Nepal: reshaping the case finding/case management strategyDinesh Mondal, Shri Prakash Singh, Narendra Kumar, et al.
The American Journal of Tropical Medicine and Hygiene|August 19, 2017
The Phenotype of Circulating Neutrophils during Visceral LeishmaniasisSmriti Sharma, Shweta Srivastva, Richard E Davis, et al.
Pageof 91